chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt developed cellulitis (left arm) and was treated with Keflex and Augmentin. Temperature peaked at 103.2 for 2.5 days. Pt also treated with Benadryl.
Received the first dose of the Pfizer Covid 19 Vaccine on Monday 01/18/2021, On Wednesday and Thursday of that week, I felt weak, Friday and Saturday I felt fine. But , Saturday Evening I started coughing with FLU like systems... low grade fever , coughing and body aches. On Sunday morning @ 11:40AM...I went to get a COVID Test. Waiting on the results. I don't know what to do about the 2nd shot on February 5th.... if the results are positive. Thanks you.
Bilateral facial paralysis. 1/16/2009 MR received for DOS 11/10-13/2008 with D/C DX: Guillain-Barre Syndrome. Pt presented to ER with 7 day hx of L eye burning, numbness of the face, facial palsy. Initially dx with Bell's Palsy by PCP. Pt developed taste alterations and facial swelling. PE (+) for bilateral facial nerve paralysis, slurred speech , decreased muscle strength shoulder area, slightly decreased DTRs. Started on steroids without progression of symptoms. D/C for outpt f/u. 11/4/09:  Medical Records and Discharge Summary for dates of service 11/10/08 to 11/13/08 received.  No new information.     11/4/09:  ICD 9 Codes received:  357.0, 344.9.
Right deltoid: red, swollen, warm to touch, blotchy, non-tender, red/swollen 7.5 cm x 10.5.  Prescribed: Amoxil 250mg, Benadryl 1 teaspoon every 4-6 hours.
NO ADVERSE EVENT AT TIME OF VACCINATION REPORT FILED DUE TO PATIENT AGE
pt stated she woke up 3 days after taking vaccination w/ swollen lips, red ring around lips and raw feeling.  Swelling has since deceased but still has red ring and lips feel irritated.
There was no allergic reaction, PT was vaccinated on 02/23/22, vaccine expired on 02/17/22.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. There was no concurrent condition or medical history reported. The reporter stated that on unknown dates improperly stored doses of VARIVAX (Merck) (lot # L023594, expiration date 26-JUN-2017; lot # L034372, expiration date 08-SEP-2017; lot # L028277, expiration date 28-JUL-2017 and lot # L037562, expiration date 29-SEP-2017) (dosage, strength and route unknown) were administered to an unspecified number of unspecified patients. No adverse effect was reported. Temperature: VARIVAX (Merck) (lot # L037562 and L028277) was 6.1 degree F. Time frame: undetermined. Previous excursion: VARIVAX (Merck) (lot # L037562 and L028277) 6 degree F for 45 minutes. 6.1 degree F for 1 hour, 14 degree F for 8 hours and 9 degree F 1 hour. Administered: yes, since the last previously reported excursion. Additional information has been requested.
C/O NAUSEA AND HEADACHE APPROX 2 HOURS AFTER ZOSTAVAX WAS GIVEN. SYMPTOMS LASTED APPROX 2 HOURS.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 15-SEP-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 2304 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Redness/itching palms and leg. Some redness ears/eye lids. Given Benadryl PO. No wheezing.
Goiter on his neck, like a huge ball; It hurts him; Hurts for him to talk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  An 18-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 18 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: GOITRE (non-serious), outcome "unknown", described as "Goiter on his neck, like a huge ball"; NECK PAIN (non-serious), outcome "unknown", described as "It hurts him"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "Hurts for him to talk".  Additional Information: Caller reported that she was calling about her 18-years-old son, who got Pfizer COVID-19 booster on Thursday. He (son) woke up yesterday, with a goiter on his neck, like a huge ball. She was reading and it was common to have something like that under an armpit. No further details were provided. She had not read any information about this issue being on the side of the neck. She said it hurts him and hurts for him to talk. She asked if her son should see a doctor and also asked if anyone else had reported the similar issue. She asked if how long it would last. She declined to complete a safety report.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Received 1st dose of Pfizer on Monday April 12. States started loosing hearing to RT ear on Tuesday April 13th. On Wednesday April 14th, started having ringing of the RT ear. No dizziness, vertigo, nausea, vomiting, fever.  Referred to ENT for f/u
No side effects reported; HCP calling to report AE for patient who received improperly stored VARIVAX on 10OCT2023. No side effects reported. No other medical information known. Operator of Device was a Healthcare Professional. HCP permission to contact obtained. See addition; This spontaneous report was received from the nurse and referred to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On 10-OCT-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #X007372, expiration date: 12-MAR-2025, administered for prophylaxis (strength, and route of administration were not provided) which improperly stored by a healthcare professional (temperature showed -9.9 C for 12 minutes, there were previous temperature excursion showed -8.8 C for 14 minutes; -13.1 C for 11 minutes). No side effects reported (no adverse event).; Sender's Comments:  US-009507513-2310USA007934:
Left arm where shot was given, underarm lymph node was swollen and hard-the size of a tennis ball. It was sore and traveled up my collar bone and neck and down into my breast. It is July and it is still swollen. My WBC is and has been extremely elevated since the booster. My liver enzymes are also elevated along with other blood work my doctor requested. My mammogram has also come back abnormal and will need to be redone along with ultrasound of left breast.
JOINTS AND MUSCLES STIFFNESS, ACHES, PAINS, SWELLING, DIZZINESS, NAUSEA.
Total body pain, felt like my muscles were being stretched, very achy, could not get comfortable, could not sleep because pain would wake me up. My arms especially hurt. It was hard to reach for items on a shelf, hands felt weak because arms were in pain. Loss of energy because I hurt all the time.
Client received flu vaccine at 930 am - At 2:30 pm client said tongue felt funny and tongue felt swollen. Speech was normal breathing normal. Referred to ER. 10/21/13 talked to client - went to MD 10/17 no more problems said her MD told her to see an allergist before receiving flu vaccine next year.
Feverish during the night. Woke up around 7:30am or 8:00am. Got up. Feeling unwell. Felt some nausea and dizziness. Nausea increased. Went to throw up in the bathroom sink and passed out. Woke up on the floor. Had hit head going down, probably on the counter. In shock, dizzy, clammy. Fever about 99.9 degrees.
1NOV96 pt adm to hosp for tx of animal bite to finger;pt stated felt discomfort p/vax;pt d/c w/o rxn noted;2NOV96 devel large area of redness to inj site;3NOV96 pt devel t102.9 w/flu-like sx;sees personal MD adm hosp
Did not know until doctor ran tests, had EKGs, echo of heart, bloodwork, most came back normal. Had high PVCs. Not receiving treatment at this time.
Presented to ED with recent episodes of epistaxis, vomiting dark blood, worsening dyspnea. A. fib with rapid ventricular rates in 150s, hypoxic, placed on 6 L NC. BP elevated 200/91. Labs significant for leukocytosis, hemoglobin 8.3.  Treated with 1 unit PRBC, Eliquis was held and Kcentra was used for reversing bleeding, diltiazem drip for A. fib RVR, continued to have worsening hypoxia and alternated between needing BiPAP and Vapotherm, treated with IV antibiotics, steroids for COVID-pneumonia and superimposed bacterial pneumonia.   Patient reported that she did not want to continue with further aggressive cares and was transitioned to inpatient hospice care. Patient expired 11/27/2022 at 1400  Submitter does not have access to patient's full medical record. If further information is needed, please contact Hospital
Following vax in 1989 & 1990, w/in 1 wk the pt was hospitalized w/ pneumonia. Though the relationship was unclear, the pt was advised to avoid vax.
Moderna vaccine booster was administered on 11/5/2021 with an expiration date of 10/11/2021. Inquiry has been submitted to Moderna requesting validation of vaccine potency.  A response from Moderna is expected to be received between 8-10 business days.  Expiration date is currently not printed on the vaccine vial or carton and vaccine expiration date listed is 12/31/2069.  To find the expiration date, ?look up expiration date? tool is to be used from Vial Expiration Date Lookup | Moderna COVID-19 Vaccine (EUA). Patient contacted on 12/4/2021 and no adverse effects reported.
On Saturday on the 16th I started itching all over my body and my head, dry mouth and my ears were itching as well. On Sunday I noticed the itching  increased after taking my  levothyroxine. The 18th I noticed the same pattern of itching increasing after taking the levothyroxine the dry mouth as continued. Have not been sleeping well. The 19th same pattern occurred. I also developed a slight headache. I have been using lots of lotion. The itching appears to worsens after taking the Levothyroxine and after showering. The 20th same thing, but the headache was worse so I took two aspirins. The 21st was a big change, my heart was racing the normal pattern but at 1pm in the afternoon while walking home I noticed a burning sensation on my rear-end. When I made it home I noticed an elongated redden area it was very red and I put some cream triple antibiotic cream on there. It was burning very badly. The evening I went back to work  my body started itching again, I noticed the area where I received the vaccine was red and hard under the skin about 3inch diameter area. Took a shower and put antibiotic cream. Today after taking my pill in the morning itching came back, and the redden area at the injection site looks like hives now . The redden area on my bottom has improved. My heart was also racing again.   I did called the hospital last night  and was supposed to receive a return call which I have not received yet.
Intermittent cramping and diahrrea from midnight Sunday through Monday 2/15 (so far)
Beginning 8th day after 1st dose of vaccine, developed swelling, warmth, redness, soreness, and itch in arm at site of injection.
Patient was diagnosed with Type I diabetes 4/24/07. Hemoglobin A1C of 11.6% suggest at least 3 month history. No relation to vaccine suspected.  06/05/2007 MR received for an o/n admission 4/24-25/2007 for c/o blurred vision and frequent urination. Mom reported wt. loss as well. Discharge DX: Type 1 diabetes-new onset.  No signs of infection.  No ketoacidosis.
This spontaneous report as received from a physician refers to a 13 year old patient of unknown gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 07-AUG-2017, the patient was vaccinated with improperly stored GARDASIL 9 lot # N000326, expiry date 14-DEC-2019 (dose, route of administration were not provided). Data logger was not involved. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012770: US-009507513-1709USA012767: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA007325: US-009507513-1709USA012766: US-009507513-1709USA012764.
His weight is fluctuating; This is a spontaneous report from a Pfizer-sponsored program. A contactable 62 years old male consumer (patient) received 1st dose of Pfizer-BioNTech Covid-19 Vaccine BNT162B2 (Lot Number: EN6203), at the age of 62 years old, on 11Mar2021 in the Left arm for covid-19 immunization. Patient History was Blood clot in both legs. No Family Medical History Relevant. Concomitant Products clopidogrel bisulfate (PLAVIX) Ongoing for Blood thinner, he began taking Plavix 2 years ago after he had blood clots in both legs. Caller reported that he was supposed to get his second dose on 01Apr2021 but was hospitalized for a bypass that he had on 26Mar2021. Patient experienced Vascular graft on 26Mar2021. His weight is fluctuating. Outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
I administered the vaccine. We were talking. The patient became quiet. I asked if he was ok, he said he felt light headed. He said his vision was blurry. I took his blood pressure - it was 160/157 and he broke a sweat, his coloring paled. I called for my tech to call 911,  pulled out my epi pen, & hit go on my bp machine again. This time it read 75/42. I administered epi pen and liquid po benadryl 25mg. His blood pressure began to normalize and his coloring began to return to normal. Bp came back to not crazy 150/85. EMS came - he went with them to the hospital.
Mother called stating patient received vaccination a few weeks ago [9/20/22] and today [10/1/22] woke up with rash all over body, mostly torso but also on elbow of arm he received shot.  She asked if it could be related to vaccine.
Tonic clonic seizure x2 mins. No fever present. Hx of 2 febrile seizures one 11/2013 and second on 1/2014.
04/19/2006 pt presented to center with temp 102.3 and left upper arm swollen, warm, erythematous. 4/20/2006 area if erythema increased. Pt admitted to hosp.
Severe chest pain, elevated troponins, and Pericarditis diagnosis on 5/26/2021, Hospital.
Onset of fever 4/25/03 with chest pain, malaise, some weakness, and generalized viral syndrome sxs. Pt. presented to Hospital ER and was admitted for possible post-vaccinia peri-myocarditis.  Verbal report called in from Dr. to Dr. on 4/26/03 for possible post-vaccinia reactions. Dr. presently unavailable to complete VAERS.
Patient received the orginal Pfizer vaccine for patients 12 and older for a booster dose rather than the bivalent as intended.  No adverse effects noted.  The original monovalent version of the vaccine was given rather than the new bivalent.
Patient stated he experienced a fever (102 degrees F)  two weeks after first dose. COVID test was negative. He also experienced soreness in armpit that started at an unknown time and lasted until fever stopped two days after starting. Patient treated with Tylenol.
Herpes Zoster; This spontaneous report was received from a lawyer regarding a case in litigation and referring to a currently 86 years old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or about 07-AUG-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose number and route was not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of herpes zoster was not reported. The reporter considered the herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 05-FEB-2016, the patient was vaccinated with improperly stored dose of ZOSTAVAX (temperature: 43 F, time frame: 44 days) (lot # L034736, exp. 01-FEB-2016, dose and route was not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the two reports from the same reporter link. Additional information has been requested.
Within 10-15 minutes of vaccine administration patient broke out in hives and itching on her left upper and lower arm. She then developed hives and itching on her right arm, right axilla, and a few erythematous areas on her nose and around her eyes.
Got two shots, still have a mild case of shingles/Suspected vaccination failure; Mild case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 08-APR-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient got the two Shingle shots and still had a mild case of the shingles. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. In 2016 these patients were vaccinated with doses of GARDASIL 9 (lot # K026247 with expiration 29-JAN-2017; dose, frequency and route were not reported), which had been improperly stored since January 2015) (incorrect product storage). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
This spontaneous report as received from a nurse refers to a 12 month old patient. The nurse reported on 17-FEB-2017, the patient inadvertently received first dose in M-M-R II (injection, lot # L036851, EXP 23-SEP-2017, subcutaneous, dose and frequency were not reported) and PROQUAD (injection, lot#M017336, EXP 05-OCT-2017, dose, route and frequency were not reported) dose series concomitantly. The nurse reported one vaccine administered in upper right arm and other vaccine administered in upper left arm. The nurse reported that there had been no call back regarding any adverse effects from the parents. Additional information has been requested.
uterine/cervical cramping for several days which was severe enough to require Motrin; blood clots on two separate occasions discharged in urine
Neck/back chest pain; Neck/back chest pain; Neck/back chest pain; dizzy; weak; fever; This is a spontaneous report from a contactable nurse (the patient). This 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9262), dose 2, single dose via an unspecified route of administration in the left arm  on 26Jan2021 at 10:00 AM (at the age of 43- years-old) for COVID-19 vaccination. The patient's medical history included hypertension, hyperlidemia, pre-cancer cells in cervix, hysterectomy and allergy to penicillin. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: ELO1423, expiration: 1/2021), single dose, dose 1  in the right arm on 05Jan2021 at 10:00 AM. Concomitant medications included atorvastatin, hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ), fluoxetine (PROZAC) and zolpidem (AMBIEN). On 27Jan2021, the patient had neck, back and chest pain, dizzy, weak and fever.  The events were reported as non-serious. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccine within 4 weeks prior to the vaccine. No therapeutic measures were taken as a result of neck, back and chest pain, dizzy, weak and fever.  The clinical outcome of neck, back and chest pain, dizzy, weak and fever was not recovered . The patient has been tested for COVID-19 since having the vaccine. On 25Jan2021, COVID rapid test was negative.
pt recvd flu vax & w/in 48 hrs pt devel soreness @ inject site;
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 19-OCT-2016, the patient was vaccinated with an improperly stored dose of PEDVAXHIB injection, lot # M007762, expiration date 07-DEC-2018 (dose, route and site of administration were not reported). There was no adverse effect reported. Product quality complaint was not involved. The administered dose of vaccine was stored in the temperature of 33 degrees Fahrenheit for 4 days and 19 hours. There were no previous temperature excursions reported. Data logger was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
20x14cm area of redness, warmth and induration right thigh surrounding DTaP and Hep A site; no fever.
Severe arm pain lasting 6-8 weeks; evaluated in ED 10 days later, skin appeared normal but tender left detltoid and limited ROM 2/2 pain.
severe stomach pain nausea & diarrhea intense pain at injection site (arm) severe fatigue
Fever, chills, joint pain, muscle pain, headache, fatigue.  Onset 9 hours after shot, lasting for 36 hours.
Pt returned for her second dose and reported Bilateral rash to hands within an hour of vaccine.
?Covid Arm? - red rash, 2?x3? at injection site, very warm to touch and itchy.  Slightly swollen.  Also, woke up with a migraine.